Emerson (EMR) PT Raised to $124 at RBC Capital
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $157.78 -2.63%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
RBC Capital analyst Deane Dray raised the price target on Emerson (NYSE: EMR) to $124.00 (from $123.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Outlook Therapeutics Inc. (OTLK) PT Lowered to $4 at Brookline Capital Markets
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
